StockNews.com began coverage on shares of Integra LifeSciences (NASDAQ:IART – Get Rating) in a report released on Thursday. The firm issued a buy rating on the life sciences company’s stock. Several other research firms have also commented on IART. Citigroup lowered their price objective on shares of Integra LifeSciences from $60.00 to $59.00 and set […]